Bank of America’s Cue Health Inc. Common Stock HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,018
Closed -$943 8524
2024
Q1
$943 Sell
5,018
-71
-1% -$16 ﹤0.01% 7207
2023
Q4
$825 Sell
5,089
-2,392
-32% -$794 ﹤0.01% 7229
2023
Q3
$3.31K Sell
7,481
-6,067
-45% -$2.77K ﹤0.01% 7068
2023
Q2
$5K Sell
13,548
-217,322
-94% -$185K ﹤0.01% 6989
2023
Q1
$420K Buy
230,870
+86,810
+60% +$189K ﹤0.01% 5488
2022
Q4
$298K Buy
144,060
+90,272
+168% +$285K ﹤0.01% 5701
2022
Q3
$162K Buy
53,788
+19,195
+55% +$68K ﹤0.01% 6106
2022
Q2
$111K Sell
34,593
-44,077
-56% -$239K ﹤0.01% 6420
2022
Q1
$507K Buy
78,670
+67,682
+616% +$612K ﹤0.01% 5821
2021
Q4
$147K Buy
+10,988
New +$121K ﹤0.01% 6673

Other funds holding HLTH

Bank of America's HLTH Position: Q2 2024 in Review

Bank of America sold out of Cue Health Inc. Common Stock (HLTH) in Q2 2024, closing a stake of 5,018 shares — an estimated $943 sold.

Bank of America first reported a position in HLTH in Q4 2021 and held it in 10 quarters. The position peaked at $507K in Q1 2022. 9 funds tracked by Wall St. Rank hold HLTH as of Q2 2024.

  • Bank of America reported no remaining Cue Health Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Bank of America sold 5,018 Cue Health Inc. Common Stock shares in Q2 2024, an estimated $943.
  • Bank of America first reported a position in Cue Health Inc. Common Stock in Q4 2021 and held it in 10 quarters.
  • Bank of America's Cue Health Inc. Common Stock position peaked at $507K in Q1 2022.
  • 9 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q2 2024.

Based on Bank of America's 13F filing for Q2 2024, filed 14 Aug 2024.